Sign In  |  Register  |  About Sunnyvale  |  Contact Us

Sunnyvale, CA
September 01, 2020 10:10am
7-Day Forecast | Traffic

  • Search Hotels in Sunnyvale

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Amgen (NQ: AMGN )

286.40 +4.41 (+1.56%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 30, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,775,942
Open 282.56
Bid (Size) 286.54 (2)
Ask (Size) 290.00 (1)
Prev. Close 281.99
Today's Range 278.93 - 287.96
52wk Range 198.64 - 296.67
Shares Outstanding N/A
Dividend Yield 2.46%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Analyst Forecasts $101-117/Share Offer Price For Horizon Therapeutics' Buyout
 
Via Benzinga
Why Horizon Therapeutics Stock Is Skyrocketing Today
Three big drugmakers could be interested in acquiring Horizon. 
Via The Motley Fool

Performance

YTD
+26.34%
+26.34%
1 Month
+5.94%
+5.94%
3 Month
+19.18%
+19.18%
6 Month
+13.01%
+13.01%
1 Year
+44.01%
+44.01%

More News

Read More
Why Is Horizon Therapeutics (HZNP) Stock Up 30% Today?
Via InvestorPlace
iPhone Pro Shipments May Miss Consensus, Tesla Rival Charts Ambitious Expansion Plan In Mexico, Amazon Cloud Unit To Add More Employees: Top Stories Wednesday, Nov. 30
Via Benzinga
$100 Invested In This Stock 15 Years Ago Would Be Worth $500 Today
Via Benzinga
Credit Suisse Sets Bearish Tone For Amgen; Says Current Setup Not Ideal For Growth
Via Benzinga
What 7 Analyst Ratings Have To Say About Amgen
Via Benzinga
Analyst Ratings for Amgen
Via Benzinga
Where Amgen Stands With Analysts
Via Benzinga
Horizon Therapeutics Shares Jump On Confirmation Of Takeover Talks With Several Large Companies
Via Benzinga
Horizon Therapeutics Rockets As It Considers Potential Bids From Amgen, J&J, Sanofi
Via Investor's Business Daily
Mild Fed Meeting Minutes Boost Stocks Ahead of Holiday
Via Talk Markets
Mirati Therapeutics Surges As Big Pharma Reportedly Preps For A Buyout Battle
Via Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Amgen Earnings Perspective: Return On Invested Capital
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 18, 2022
Via Benzinga
2 Stocks to Buy Whether or Not a Recession Is Coming
Via The Motley Fool
7 Top-Tier Dividend Stocks to Buy for 2023
Via InvestorPlace
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
How Is The Market Feeling About Amgen?
Via Benzinga
Biotech Sector Witnessing Growing Revenue Potential in Ongoing Battle Against Pancreatic Cancer
Via FinancialNewsMedia
Topics Death
Exposures Death
Can This Company's Research Help Transform Regenerative Medicine As Its Lead Product Receives FDA IND Approval?
Via Benzinga
This US Representative Just Bought Shares Of Airbnb And These 2 Dividend-Paying Stocks
Via Benzinga
Stock Market Rally Roars Higher On Cooling Inflation; Bitcoin, Meta, Tesla In Focus: Weekly Review
Via Investor's Business Daily
Is Mid-Cap Neurocrine Biosciences A Buy After Blowout Q3 Report?
Via MarketBeat
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Sunnyvale.com & California Media Partners, LLC. All rights reserved.